These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21410840)

  • 41. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan.
    Kapp N; Todd CS; Yadgarova KT; Alibayeva G; Nazarova D; Loza O; Babadjanova GS
    Contraception; 2007 Dec; 76(6):461-6. PubMed ID: 18061705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective double-blinded, randomized, placebo-controlled trial on the use of letrozole pretreatment with misoprostol for second-trimester medical abortion.
    Lee VC; Tang OS; Ng EH; Yeung WS; Ho PC
    Contraception; 2011 Dec; 84(6):628-33. PubMed ID: 22078193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose vaginal misoprostol in the management of intrauterine fetal death.
    El-Gharib MN; Elebyary MT
    J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1239-42. PubMed ID: 21714693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Termination of pregnancy in patients with previous cesarean section.
    Mazouni C; Provensal M; Porcu G; Guidicelli B; Heckenroth H; Gamerre M; Bretelle F
    Contraception; 2006 Mar; 73(3):244-8. PubMed ID: 16472563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of 400 or 600 micrograms of vaginal misoprostol for terminations of early pregnancies.
    Ruangchainikhom W; Phongphissanou E; Bhekasuta J; Sarapak S
    J Med Assoc Thai; 2006 Jul; 89(7):928-33. PubMed ID: 16881422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming?
    Singh K; Fong YF; Prasad RN; Dong F
    Hum Reprod; 1999 Jun; 14(6):1635-7. PubMed ID: 10357990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second trimester pregnancy termination with 800 mcg vaginal misoprostol.
    Pongsatha S; Tongsong T
    J Med Assoc Thai; 2001 Jun; 84(6):859-63. PubMed ID: 11556466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Misoprostol for second trimester pregnancy termination in women with prior caesarean section.
    Daskalakis GJ; Mesogitis SA; Papantoniou NE; Moulopoulos GG; Papapanagiotou AA; Antsaklis AJ
    BJOG; 2005 Jan; 112(1):97-9. PubMed ID: 15663405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second-trimester pregnancy interruption with vaginal misoprostol in women with previous cesarean section.
    Pongsatha S; Tongsong T
    J Med Assoc Thai; 2006 Aug; 89(8):1097-100. PubMed ID: 17048415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section.
    Daponte A; Nzewenga G; Dimopoulos KD; Guidozzi F
    Contraception; 2006 Oct; 74(4):324-7. PubMed ID: 16982234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Second trimester abortion using intravaginal misoprostol.
    Herabutya Y; O-Prasertsawat P
    Int J Gynaecol Obstet; 1998 Feb; 60(2):161-5. PubMed ID: 9509955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Misoprostol preferable to ethacridine lactate for abortions at 13-20 weeks of pregnancy: Cuban experience.
    Boza AV; de León RG; Castillo LS; Mariño DR; Mitchell EM
    Reprod Health Matters; 2008 May; 16(31 Suppl):189-95. PubMed ID: 18772100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion.
    Creinin MD; Carbonell JL; Schwartz JL; Varela L; Tanda R
    Contraception; 1999 Jan; 59(1):11-6. PubMed ID: 10342081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaginal acidity enhancement with a 3% acetic acid gel prior to misoprostol treatment for pregnancy termination in the midtrimester.
    Abd-El-Maeboud KH; Ghazy A; Ibrahim A; Hassan N; El-Bohoty A; Gamal-El-Din I
    Int J Gynaecol Obstet; 2012 Dec; 119(3):248-52. PubMed ID: 22980429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic termination of second trimester pregnancy with vaginal misoprostol.
    Pongsatha S; Tongsong T; Suwannawut O
    J Med Assoc Thai; 2001 Apr; 84(4):515-9. PubMed ID: 11460962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One or two day mifepristone-misoprostol interval for second trimester abortion.
    Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
    Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sublingual versus vaginal misoprostol (400 microg) for cervical priming in first-trimester abortion: a randomized trial.
    Carbonell Esteve JL; Marí JM; Valero F; Llorente M; Salvador I; Varela L; Leal P; Candel A; Tudela A; Serrano M; Muñoz E
    Contraception; 2006 Oct; 74(4):328-33. PubMed ID: 16982235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.